"10.1371_journal.pone.0090772","plos one","2014-03-13T00:00:00Z","Cissy Kityo; Diana M Gibb; Charles F Gilks; Ruth L Goodall; Ivan Mambule; Pontiano Kaleebu; Deenan Pillay; Ronnie Kasirye; Peter Mugyenyi; A Sarah Walker; David T Dunn; on behalf of the DART Trial Team","Joint Clinical Research Centre, Kampala, Uganda; MRC Clinical Trials Unit at UCL, London, United Kingdom; School of Population Health, University of Queensland, Australia; Infectious Diseases Institute, Mulago, Uganda; MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda; University College London, London, United Kingdom","Conceived and designed the experiments: CK DMG ASW DTD. Performed the experiments: CK IM PK RK PM. Analyzed the data: DD RLG ASW. Wrote the paper: CK DTD CFG ASW DMG DP.","The authors have the following interests: GlaxoSmithKline, Gilead Sciences, Boehringer-Ingelheim and Abbott Laboratories donated drugs for DART. GlaxoSmithKline donated Combivir and abacavir; Gilead Sciences donated tenofovir; Boehringer-Ingelheim donated nevirapine; Abbott Laboratories donated Kaletra/Aluvia. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","03","Cissy Kityo","CK",12,TRUE,4,5,3,6,TRUE,FALSE,TRUE,1,"12",TRUE
